Sherry Higginbotham
Optometrist · Reisterstown, MDNPI 1013975796
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $609 of the $685 with a category attached, or 89.0%. It is spread thinly across 13 manufacturers, the largest accounting for just 18.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $260 and has fallen 72.7% since, to $71 in 2024. That places this record below the midpoint for optometrist clinicians in MD, where the typical reported total is $712.
Across 18 payments — averaging $38.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$124
- Abbott$122
- Bausch & Lomb Americas Inc.$103
- Merck$68
- Alcon$63
- Carl Zeiss Meditec AG$58
- plus $147 from 7 others
What the payments were for
- Food & beverage$60989%
- Gifts$7511%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 1 | $124 |
| Abbott | 1 | $122 |
| Bausch & Lomb Americas Inc. | 1 | $103 |
| Merck | 1 | $68 |
| Alcon | 4 | $63 |
| Carl Zeiss Meditec AG | 3 | $58 |
| Sun Pharmaceutical Industries Inc. | 1 | $25 |
| Coopervision Inc. | 1 | $24 |
| Amgen | 1 | $23 |
| Oyster Point Pharma, Inc. | 1 | $23 |
| Dompe US, Inc. | 1 | $18 |
| Novo Nordisk | 1 | $17 |
| Carl Zeiss Meditec, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QULIPTA$124
- UBRELVY$124
- FreeStyle Libre$122
How this compares
$685 in reported general payments places this provider in the 45th percentile of 790 optometrist providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Latanoprost | 79 | $798 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 20 | $564 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Reisterstown
- Susan LathropFulton$337K
- Timothy EarleyOakland$276K
- Padmini NathanFrederick$199K
- Alan GlazierRockville$87K
- Andrew MorgensternBethesda$62K
- Devin SasserSilver Spring$40K
- Rizwana IqbalEllicott City$34K
- Brian WoolfPasadena$19K
- Vickie FangGaithersburg$17K
- Aaron WeinsteinWaldorf$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.